Achieving patient centricity: 4 key lessons from orphan disease companies
Publication

October 11, 2016

Achieving patient centricity: 4 key lessons from orphan disease companies

Orphan drugs – leading the way in patient centricity
Publication

October 10, 2016

Orphan drugs – leading the way in patient centricity

Recorded Webinar: How to strengthen Market Access
Publication

October 03, 2016

Recorded Webinar: How to strengthen Market Access

Strengthening market access deliverables by harnessing the patient journey
Publication

September 27, 2016

Strengthening market access deliverables by harnessing the patient journey

Biopharma without borders - commercial model for niche specialty care and orphan products
Publication

September 15, 2016

Biopharma without borders - commercial model for niche specialty care and orphan products

The case for Market Access leadership in brand team integration
Publication

May 31, 2016

The case for Market Access leadership in brand team integration

Medical Affairs- The time for change is now
Publication

May 09, 2016

Medical Affairs- The time for change is now

Current perspectives on the biopharma go-to-market model
Publication

January 04, 2016

Current perspectives on the biopharma go-to-market model

4 Steps to unlocking long-term funding for innovative therapies in the hospital setting
Publication

January 01, 2016

4 Steps to unlocking long-term funding for innovative therapies in the hospital setting

Severe Weather Warning – Shaping a market access strategy to navigate choppy local waters
Publication

September 08, 2015

Severe Weather Warning – Shaping a market access strategy to navigate choppy local waters

Stakeholder and KOL Management: Taking the pulse
Publication

August 03, 2015

Stakeholder and KOL Management: Taking the pulse

A call for action for Global and Regional MA: facilitate local payer engagement
Publication

June 17, 2015

A call for action for Global and Regional MA: facilitate local payer engagement